Get the app
US › Healthcare

Turn Therapeutics Inc. Common Stock (TTRX)

US · Healthcare · Biotechnology

$9.48+6.04%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-5.8M
EPS
$-0.07
EPS estimate
$-0.02

EPS came in at -0.07 against a street estimate of -0.02 — a miss of 250.0%.

Key statistics

Market cap
$271.5M
Forward P/E
0.0
P/B
420.44
Book value
$0.02
EPS (TTM)
$-0.29
52-week high
$16.45
52-week low
$2.57
50-day MA
$11.73
200-day MA
$7.08

Analyst view

Analysts rate Turn Therapeutics Inc. Common Stock a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $25.00.

Shareholding

Insiders
52.90%
Institutions
3.78%

Largest institutional holders

FundStake
Steel Peak Wealth Management LLC0.84%
IEQ CAPITAL, LLC0.76%
DDFG Inc0.37%
Vanguard Capital Management, LLC0.25%
Wellington Shields & Co., LLC0.22%
Millennium Management LLC0.20%
BlackRock Inc0.13%
Aaron Wealth Advisors LLC0.11%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Turn Therapeutics Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.